现金9亿美金"子弹充足"!Viking能否复制礼来神话?

美港股观察社
25 Feb

作者:Biotech Beast编译:美港股观察社2024年4月,Viking Therapeutics公布口服VK2735在肥胖/超重患者中的1期临床数据。哪怕随着用药时间的延长和口服药物剂量的增加,该药品有可能会实现更显著的减重效果,但股价依旧下跌了近50%。此外,尽管存在各种收购猜测,但目前尚未有实质性的进展。当然,多头可能会认为,鉴于股价的下跌,该股票现在更具吸引力。而且,依旧值得回顾一下...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10